(Q44616173)
Statements
Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study (English)
Christine Wolschke
Thomas Stübig
Ute Hegenbart
Marion Heinzelmann
York Hildebrandt
Djordje Atanackovic
Peter Dreger
Axel Zander
Nicolaus Kröger
17 October 2012